The pathological status of the mdx mouse model of Duchenne muscular dystrophy is based on a point mutation in exon 23 of the dystrophin gene, resulting in a truncated protein product that is quickly degraded in dystrophic fibres [61]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.